Results 111 to 120 of about 2,690,721 (162)

Combined Oral Anticoagulant and Antiplatelet for Atrial Fibrillation and Cerebral Atherosclerosis: A Meta-Analysis. [PDF]

J Stroke
Lee H, Heo J, Jung JW, Nam HS, Kim YD.
europepmc   +1 more source

High Remnant Cholesterol Increased the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) or Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis. [PDF]

J ASEAN Fed Endocr Soc
Biya T, Sanusi H, Aman AM.
europepmc   +1 more source

The two faces of medical evidence

Swiss Medical Weekly, 2002
Uexküll von, JM Herrmann
doaj   +1 more source

U.S. policy responses to xylazine: Thinking bigger. [PDF]

Int J Drug Policy
Harvey LH, Green TC, Park JN, Rich JD.
europepmc   +1 more source

When to Continue, Pause, or Stop SGLT-2 Inhibitors in Heart Failure: A Complication-based Clinical Guide. [PDF]

J Community Hosp Intern Med Perspect
Tesoro NA, Manha JK, Bandaru SK.
europepmc   +1 more source

Efficacy and Safety of Surgical Resection in Elderly Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. [PDF]

Gut Liver
Lee JS, Park DA, Ryoo S, Park J, Choi GH, Yoo JJ.   +5 more
europepmc   +1 more source

Future scenarios of radioligand therapy in pheochromocytomas and paragangliomas. [PDF]

EJNMMI Rep
Pacella S, Elisei F, Mattoli MV, Airò Farulla LS, Aliberti G, Rizzo A, Maccauro M.   +6 more
europepmc   +1 more source

Domain-Adapted Foundation Models for Single-Click Surgical Instrument Segmentation in Spinal Endoscopy. [PDF]

Neurospine
Mun BS, Zhao Z, Park SM, Park J, Park HJ, Lee HR, Kim HJ, Yeom JS.   +7 more
europepmc   +1 more source

Gaining market share for health: A social marketing framework for implementation science. [PDF]

Health Mark Q
Biroscak BJ.
europepmc   +1 more source